BNTX Congressional Stock Trades
BioNTech SE - American Depositary Shares
Last disclosed trade Sep 3
Every disclosed trade in BNTX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every healthcare stock Congress trades.
Sample · the intelligence layer
Josh Gottheimer · Sold $BNTX · Aug 30 · $1K–$15K
Managed-account penalty applied (x 0.20): filings dominated by trust or wealth-manager activity are discounted.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $BNTX
Get notified when any member of Congress trades $BNTX. Free, no card, no spam.
The record on $BNTX
Coldpine has parsed 7 disclosed trades in $BNTX by 1 member of Congress, drawn from 5 periodic transaction reports dated Dec 5, 2023 through Sep 3, 2024. All of them came from House members, all filed by Democrats.
Of the 7 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 30 days. The longest was 33 days: a $BNTX purchase by Josh Gottheimer dated Dec 5, 2023, disclosed Jan 7, 2024. How late filing is measured across all of Congress is in the late-filers study.
7 of the 7 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Activity peaked in 2024 with 4 trades.
Members who trade BNTX
Recent disclosed trades in BNTX
| Date | Member | Type | Amount |
|---|---|---|---|
| Sep 3 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Aug 30 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Apr 15 | Josh Gottheimer(NJ) | buy | $1K–$15K |
| Mar 14 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Dec 7 | Josh Gottheimer(NJ) | buy | $1K–$15K |
| Dec 6 | Josh Gottheimer(NJ) | buy | $1K–$15K |
| Dec 5 | Josh Gottheimer(NJ) | buy | $1K–$15K |
From Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →